The discovery of the placental growth factor and its role in angiogenesis: A historical review

Domenico Ribatti

Research output: Contribution to journalArticle

Abstract

The placental growth factor (PlGF) is an angiogenic protein belonging to the vascular endothelial growth factor (VEGF) family, which was discovered in 1991 by an Italian scientist, Maria Graziella Persico. Dr Persico cloned and purified PlGF and determined its structure by crystallography resolution. Furthermore, she identified VEGF receptor-1 (VEGFR-1) as the receptor for PlGF, and in collaboration with Dr Peter Carmeliet in Leuven, she generated evidence that loss of PlGF does not affect development, reproduction, or postnatal life. PlGF is expressed primarily in the placenta and is up-regulated in several pathological conditions, although its role is still controversial. Some data in literature reported that PlGF enhances pathological angiogenesis by initiating a cross-talk between VEGFR-1 and VEGFR-2, whereas other studies did not confirm these findings. Regarding the potential therapeutic employment of PlGF, recent evidence has shown that an anti-PlGF antibody may act as a potent antiangiogenic agent, and that it has the advantage of minor toxicity when combined with anti-VEGF strategies.

Original languageEnglish
Pages (from-to)215-221
Number of pages7
JournalAngiogenesis
Volume11
Issue number3
DOIs
Publication statusPublished - Sep 2008

Fingerprint

Intercellular Signaling Peptides and Proteins
Vascular Endothelial Growth Factor A
Angiogenic Proteins
Pathologic Neovascularization
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2
Crystallography
Vascular Endothelial Growth Factor Receptor
Angiogenesis Inhibitors
Growth Factor Receptors
Placenta
Reproduction
Toxicity
Antibodies
Proteins

Keywords

  • Angiogenesis
  • Antiangiogenesis
  • History of medicine
  • Placental growth factor
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Cancer Research
  • Clinical Biochemistry
  • Polymers and Plastics
  • Pathology and Forensic Medicine

Cite this

The discovery of the placental growth factor and its role in angiogenesis : A historical review. / Ribatti, Domenico.

In: Angiogenesis, Vol. 11, No. 3, 09.2008, p. 215-221.

Research output: Contribution to journalArticle

@article{e4ab17719fa047d887046b1649b11d25,
title = "The discovery of the placental growth factor and its role in angiogenesis: A historical review",
abstract = "The placental growth factor (PlGF) is an angiogenic protein belonging to the vascular endothelial growth factor (VEGF) family, which was discovered in 1991 by an Italian scientist, Maria Graziella Persico. Dr Persico cloned and purified PlGF and determined its structure by crystallography resolution. Furthermore, she identified VEGF receptor-1 (VEGFR-1) as the receptor for PlGF, and in collaboration with Dr Peter Carmeliet in Leuven, she generated evidence that loss of PlGF does not affect development, reproduction, or postnatal life. PlGF is expressed primarily in the placenta and is up-regulated in several pathological conditions, although its role is still controversial. Some data in literature reported that PlGF enhances pathological angiogenesis by initiating a cross-talk between VEGFR-1 and VEGFR-2, whereas other studies did not confirm these findings. Regarding the potential therapeutic employment of PlGF, recent evidence has shown that an anti-PlGF antibody may act as a potent antiangiogenic agent, and that it has the advantage of minor toxicity when combined with anti-VEGF strategies.",
keywords = "Angiogenesis, Antiangiogenesis, History of medicine, Placental growth factor, Vascular endothelial growth factor",
author = "Domenico Ribatti",
year = "2008",
month = "9",
doi = "10.1007/s10456-008-9114-4",
language = "English",
volume = "11",
pages = "215--221",
journal = "Angiogenesis",
issn = "0969-6970",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - The discovery of the placental growth factor and its role in angiogenesis

T2 - A historical review

AU - Ribatti, Domenico

PY - 2008/9

Y1 - 2008/9

N2 - The placental growth factor (PlGF) is an angiogenic protein belonging to the vascular endothelial growth factor (VEGF) family, which was discovered in 1991 by an Italian scientist, Maria Graziella Persico. Dr Persico cloned and purified PlGF and determined its structure by crystallography resolution. Furthermore, she identified VEGF receptor-1 (VEGFR-1) as the receptor for PlGF, and in collaboration with Dr Peter Carmeliet in Leuven, she generated evidence that loss of PlGF does not affect development, reproduction, or postnatal life. PlGF is expressed primarily in the placenta and is up-regulated in several pathological conditions, although its role is still controversial. Some data in literature reported that PlGF enhances pathological angiogenesis by initiating a cross-talk between VEGFR-1 and VEGFR-2, whereas other studies did not confirm these findings. Regarding the potential therapeutic employment of PlGF, recent evidence has shown that an anti-PlGF antibody may act as a potent antiangiogenic agent, and that it has the advantage of minor toxicity when combined with anti-VEGF strategies.

AB - The placental growth factor (PlGF) is an angiogenic protein belonging to the vascular endothelial growth factor (VEGF) family, which was discovered in 1991 by an Italian scientist, Maria Graziella Persico. Dr Persico cloned and purified PlGF and determined its structure by crystallography resolution. Furthermore, she identified VEGF receptor-1 (VEGFR-1) as the receptor for PlGF, and in collaboration with Dr Peter Carmeliet in Leuven, she generated evidence that loss of PlGF does not affect development, reproduction, or postnatal life. PlGF is expressed primarily in the placenta and is up-regulated in several pathological conditions, although its role is still controversial. Some data in literature reported that PlGF enhances pathological angiogenesis by initiating a cross-talk between VEGFR-1 and VEGFR-2, whereas other studies did not confirm these findings. Regarding the potential therapeutic employment of PlGF, recent evidence has shown that an anti-PlGF antibody may act as a potent antiangiogenic agent, and that it has the advantage of minor toxicity when combined with anti-VEGF strategies.

KW - Angiogenesis

KW - Antiangiogenesis

KW - History of medicine

KW - Placental growth factor

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=48749111875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749111875&partnerID=8YFLogxK

U2 - 10.1007/s10456-008-9114-4

DO - 10.1007/s10456-008-9114-4

M3 - Article

C2 - 18568405

AN - SCOPUS:48749111875

VL - 11

SP - 215

EP - 221

JO - Angiogenesis

JF - Angiogenesis

SN - 0969-6970

IS - 3

ER -